1
Uytdehaag Alphonsus Gerardus Cornelis Maria, Schouten Govert Johan, Goudsmit Jaap: Vaccines against west nile virus. Crucell Holland, Uytdehaag Alphonsus Gerardus Cornelis Maria, Schouten Govert Johan, Goudsmit Jaap, KLEIN Bart, May 21, 2004: WO/2004/042042 (10 worldwide citation)

The present invention relates to novel vaccines containing (whole-inactivated) West Nile Viruses and/or West Nile viral proteins derived there from, produced on human cells, wherein the human cells comprise a sequence encoding at least one early region-1 (El) gene product of an adenovirus. The cells ...


2
Ter, Meulen Jan Henrik, Goudsmit Jaap, Slootstra Jelle Wouter, Timmerman Peter, Puijk Wouter Cornelis: Antigenic peptides of sars coronavirus and uses thereof. Crucell Holland, Ter, Meulen Jan Henrik, Goudsmit Jaap, Slootstra Jelle Wouter, Timmerman Peter, Puijk Wouter Cornelis, KLEIN Bart, December 23, 2004: WO/2004/111081 (6 worldwide citation)

The present invention pertains to antigenic peptides of SARS-CoV spike protein and their use in diagnostic test methods and in the treatment of condition resulting from SARS-CoV. Furthermore, this invention provides antibodies capable of specifically recognizing the peptides of the invention. The an ...


3
Ter, Meulen Jan Henrik, Goudsmit Jaap, Slootstra Jelle Wouter, Timmerman Peter, de, Kruif Cornelis Adriaan, Van Den, Brink Edward Norbert: Antigenic peptides of sars coronavirus and uses thereof. Crucell Holland, Ter, Meulen Jan Henrik, Goudsmit Jaap, Slootstra Jelle Wouter, Timmerman Peter, de, Kruif Cornelis Adriaan, Van Den, Brink Edward Norbert, CRUCELL HOLLAND, February 10, 2005: WO/2005/012337 (5 worldwide citation)

The present invention pertains to antigenic peptides of SARS-CoV and their use in diagnostic test methods and in the treatment of condition resulting from SARS-CoV. Furthermore, this invention provides antibodies capable of specifically recognizing the peptides of the invention. The antibodies can a ...


4
Ter, Meulen Jan Henrik, Goudsmit Jaap, Slootstra Jelle Wouter, Timmerman Peter: Antigenic peptides of sars coronavirus and uses thereof. Crucell Holland, Ter, Meulen Jan Henrik, Goudsmit Jaap, Slootstra Jelle Wouter, Timmerman Peter, February 10, 2005: WO/2005/012338 (5 worldwide citation)

The present invention pertains to antigenic peptides of SARS-CoV and their use in diagnostic test methods and in the treatment of condition resulting from SARS-CoV. Furthermore, this invention provides antibodies capable of specifically recognizing the peptides of the invention. The antibodies can a ...


5
Ter, Meulen Jan Henrik, de, Kruif Cornelis Adriaan, Van Den, Brink Edward Norbert, Goudsmit Jaap: Binding molecules against sars-coronavirus and uses thereof. Crucell Holland, Ter, Meulen Jan Henrik, de, Kruif Cornelis Adriaan, Van Den, Brink Edward Norbert, Goudsmit Jaap, CRUCELL HOLLAND, February 10, 2005: WO/2005/012360 (5 worldwide citation)

The present invention provides binding molecules that specifically bind to SARS-CoV, nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules are capable of specifically b ...


6
Pau Maria Grazia, Goudsmit Jaap, Cohen Joseph D, Dubois Patrice M, Stewart V Ann, Heppner Donald: Malaria prime/boost vaccines. Crucell Holland, Glaxosmithkline Biologicals, The Government Of The United, States Represented By The, Secretary Of The, Army On Behalf Of The, Walter Reed Army Institute Of Research, Pau Maria Grazia, Goudsmit Jaap, Cohen Joseph D, Dubois Patrice M, Stewart V Ann, Heppner Donald, KLEIN Bart, April 20, 2006: WO/2006/040334 (4 worldwide citation)

The invention relates to novel vaccine regimens in which specific prime/boost regimens are applied using low-neutralized recombinant adenoviral vectors harboring nucleic acids encoding antigens from Plasmodium falciparum and purified recombinant protein vaccines such as RTS,S, in the context of appr ...


7
Bakker Alexander Berthold Hendrik, Marissen Willem Egbert, Goudsmit Jaap: Antigenic peptides of rabies virus and uses thereof. Crucell Holland, Bakker Alexander Berthold Hendrik, Marissen Willem Egbert, Goudsmit Jaap, March 17, 2005: WO/2005/023849 (3 worldwide citation)

The present invention pertains to antigenic peptides of rabies virus and their use in the detection, prevention and/or treatment of conditions resulting from rabies virus.


8
Sullivan Nancy, Chakrabarti Bimal, Yang Zhi Yong, Pau Maria Grazia, Goudsmit Jaap, Nabel Gary J: Optimized vaccines to provide protection against ebola and other viruses. The Government Of The United States Of, America Represented By, The Secretary Department Of Health And Human Services, Crucell Holland, Sullivan Nancy, Chakrabarti Bimal, Yang Zhi Yong, Pau Maria Grazia, Goudsmit Jaap, Nabel Gary J, ALTMAN Daniel E, April 6, 2006: WO/2006/037038 (3 worldwide citation)

The invention is related to a nucleic acid molecule comprising a polynucleotide encoding a modified filovirus glycoprotein (GP) having at least one amino acid change located in a relatively conserved region of said GP that decreases in vitro cytotoxicity and retains immunogenicity when compared to i ...


9
Ter, Meulen Jan Henrik, Van Den, Brink Edward Norbert, de, Kruif Cornelis Adriaan, Goudsmit Jaap: Compositions against sars-coronavirus and uses thereof. Crucell Holland, Ter, Meulen Jan Henrik, Van Den, Brink Edward Norbert, de, Kruif Cornelis Adriaan, Goudsmit Jaap, sKLEIN Bart, May 18, 2006: WO/2006/051091 (1 worldwide citation)

The present invention provides compositions of binding molecules specifically binding to a coronavirus such as SARS-CoV and capable of neutralizing an infection caused by the virus. The compositions are suitable for diagnosing, preventing and/or treating a condition resulting from a coronavirus such ...


10
Goudsmit Jaap, Meloen Robert Hans: Oligopeptides et leur utilisation aux fins de diagnostic et comme vaccins pour le sida et larc, Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc. Goudsmit Jaap, Meloen Robert Hans, Stichting Centraal Diergeneeskundig Instituut, Academisch Ziekenhuis Bij de Universiteit Van Amsterdam, BORDEN LADNER GERVAIS, February 29, 2000: CA1340914

The invention relates to oligopeptides havingutility in diagnosis of, or vaccination against AIDSand ARC, and to antibodies raised against such oligopeptides. The oligopeptides have a length of 8 to 17 amino acids. The amino acid sequence corresponds to a sequence occurringin the V3 region of gp120 ...